$LJPC LA JOLLA PHARMACEUTICAL CO Insider Trading
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO. Insider overview, share value development, latest insider transactions and email notifications about new events in LA JOLLA PHARMACEUTICAL CO for free.
CIK Number: 0000920465
IRS Number: 330361285
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: LJPC
Company Address: 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO 92121
Phone number: 858-207-4264
Market Capitalization: $355.22M
Prev close: $19.47
Average Daily Volume: 122,160
Days Low: $19.17
Year Low: $13.18
Year High: $28.20
LA JOLLA PHARMACEUTICAL CO Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.30 | 169 | 727 | 169 | |
Jun 02 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.66 | 169 | 618 | 3,934 | 3.8 K to 3.9 K (+4.49 %) |
May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 3.76 | 358 | 1,346 | 358 | |
May 18 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.20 | 358 | 1,144 | 984 | 626 to 984 (+57.19 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.44 | 304 | 1,350 | 304 | |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.77 | 304 | 1,147 | 626 | 322 to 626 (+94.41 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.44 | 163 | 724 | 163 | |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.77 | 163 | 615 | 3,572 | 3.4 K to 3.6 K (+4.78 %) |
May 04 2021 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 4.53 | 30,000 | 135,900 | 30,000 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Option Exercise | A | 4.18 | 322 | 1,346 | 322 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Option Exercise | A | 4.18 | 173 | 723 | 173 | |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Edwards Larry G. | Chief Executive Off ... | Grant | A | 3.55 | 322 | 1,144 | 322 | 0 to 322 |
Apr 19 2021 | LJPC | LA JOLLA PHARMACEU ... | Hearne Michael S | Chief Financial Off ... | Grant | A | 3.55 | 173 | 615 | 3,835 | 3.7 K to 3.8 K (+4.72 %) |